(888)552-6760 安排咨询
Precision-Medicine

精密医学

此页面在我们的下面进行了审查医学和社论政策经过
Maurie Markman,,,,MD, President, Medicine & Science at CTCA.

此页面于2022年4月29日更新。

什么是精密医学?

Understanding precision cancer care and the options available often requires navigating new and complex health information. The precision medicine experts,遗传顾问andsupportive care cliniciansat Cancer Treatment Centers of America®(CTCA), help to explain what you can expect from a genetics or genomic test, how that information may be used in developing a treatment or prevention plan and whether a clinical trial may be a viable option. Also, as part of our comprehensive approach to cancer treatment, we have a panel of experts, called a molecular tumor board, who meet regularly to share information and ideas on how to treat each patient's disease. These experts collaborate on a treatment plan personalized to fit the patient’s needs, monitoring the patient’s progress throughout treatment and making adjustments when necessary.

因为精密医学是医学的快速发展领域,所以晚期基因组测试和创新治疗,例如targeted therapyandimmunotherapy应在医生和患者之间进行彻底讨论之后,并根据每个患者的独特情况进行彻底讨论。

我们的服务

Advanced genomic testing

在CTCA®,我们使用精密医学的工具来确定使特定癌症的行为方式的原因。对于某些患者而言,可能包括观察整个人类基因组,这可能会发现可以与靶向治疗方案相匹配的突变。

Advancements happen quickly in the field of遗传学和基因组学。2018年,美国国立卫生研究院(NIH)推出了我们所有的研究计划这是一项旨在在十年内对整个美国一百万个基因组进行测序的公共卫生计划。他们收集的信息可以改变我们与普通癌症的战斗方式,例如肺癌and乳腺癌

As precision medicine research continues to rapidly evolve, our oncology team is prepared to make a cancer care plan tailored to an individual's genetic makeup, using the advances in pharmacogenomics, big data analytics, artificial intelligence and biomarker testing (also called tumor profiling or next generation sequencing). The experts at our cancer centers also consider genetic information about the type of cancer you have, such as the mutator phenotype, when developing a medical treatment plan.

了解有关高级基因组测试的更多信息。

Genetic testing

According to the国家癌症研究所,,,,"Harmful variants in some genes are known to be associated with an increased risk of developing cancer. These inherited variants are thought to contribute to about 5 to 10 percent of all cancers."

A genetic test may help determine if a patient was born with a higher risk of developing cancer due to a particular inherited基因突变or series of gene mutations. Being diagnosed with a hereditary condition may empower patients to make more informed decisions about how to manage their cancer risks.

了解有关基因检测的更多信息。

Genetic counseling

如果您知道或怀疑您有一个基因突变由于特定疾病的家族史,这可能会增加您的癌症风险leukemia,,,,黑色素瘤,,,,结直肠癌or卵巢癌,您可以考虑遗传咨询。我们的遗传辅导员帮助患者了解有助于降低癌症风险和/或增加在其早期癌症的机会的策略。

了解有关遗传咨询的更多信息。

Targeted therapy

可以根据晚期基因组检验的结果进行靶向治疗药物来治疗某些癌症。这些药物旨在寻找癌细胞独有的特征,并靶向特定的蛋白质或mutationsthat may be driving the cancer's growth.

了解有关目标疗法的更多信息。

Immunotherapy

研究人员开发了一系列称为的免疫疗法药物检查点抑制剂designed to energize the body's immune system to better recognize and attack cancer cells. These drugs are designed to expose cancer cells as invaders, triggering an immune response.

了解有关免疫疗法的更多信息。

Clinical trials

CTCA致力于使我们的患者创新癌症treatment options。我们的临床试验explore treatment options that may lead to tomorrow’s medicine and offer patients treatments that may not otherwise be available to them. These studies are an essential testing ground for measuring the safety, effectiveness and potential side effects of drugs and other treatments before they can be granted government approval.

其中之一临床试验is the目标代理和分析利用率注册表(TAPUR)研究。由美国临床肿瘤学会(ASCO)领导,并提供所有CTCA医院,该研究旨在通过将药物与具有特定的肿瘤相匹配,以提高我们对市售抗癌药物在更广泛癌症上的性能的理解基因组突变这些药物被设计为靶向。与其他临床试验一样,这项研究不适合或适合所有患者。您的护理团队将与您合作,确定您是tap的候选人还是我们正在进行的其他临床试验之一。

学到更多about clinical trials.

Supportive care services

患者护理不是一定程度的全部。除了个性化医学外,我们还提供各种证据信息支持护理疗法, 如nutritional supportand行为健康,帮助患者保持治疗的力量。我们还提供咨询,精神上的支持以及其他服务,以帮助患者应对焦虑和压力。

了解有关支持护理服务的更多信息。

专家癌症护理

是一个电话。
约会在24小时。

新研究

提供有关新的和新兴癌症治疗选择的临床试验。

查看我们的临床试验

What’s your risk?

Assess your cancer risk and take control

Assess your cancer risk

Insurance plans

我们接受广泛的保险计划。

验证您的保险